Feasibility Study of the Instrumented Evaluation of Eccentric Strengthening in Paresis Patients (RE PAR EX)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT05415514|
Recruitment Status : Not yet recruiting
First Posted : June 13, 2022
Last Update Posted : June 13, 2022
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
he aim of the "RE PAR EX" research is to evaluate the feasibility of the instrumented examination of the effects of eccentric muscle strengthening in paralytic patients. This project is part of the research axis of the movement analysis laboratory.
Following a stroke or spinal cord injury, patients develop a spastic paresis syndrome, which is characterized by the appearance of paresis, musculo-tendinous retractions and muscular hyperactivities.
If the traditional treatments proposed (stretching, motor work) show limits, the use of eccentric muscle strengthening in paresis patients has been developing for about ten years, with results superior to the usual treatments. The results of the studies evaluating it are focused on clinical evaluations and do not make it possible to identify the precise origin of the observed responses.
A pathophysiological understanding of the therapeutic effects of eccentric strengthening would be possible through instrumented examination of muscle structure and function, combining dynamometry, ultrasound, elastrography and electromyography (EMG). However, the feasibility of this quantified instrumental examination in paretic patients during a strengthening protocol has not been evaluated.
The feasibility of a quantified instrumented examination in this setting is the aim of this research, a necessary prerequisite for a larger interventional study to evaluate the biomechanical and neurophysiological effects of eccentric muscle strengthening in paretic patients.
|Condition or disease||Intervention/treatment||Phase|
|Paralysis||Other: Instrumented assessment of muscle function||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||10 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||instrumented evaluations|
|Masking:||None (Open Label)|
|Official Title:||Feasibility Study of the Instrumented Evaluation of Eccentric Strengthening in Paresis Patients|
|Estimated Study Start Date :||September 2022|
|Estimated Primary Completion Date :||July 2024|
|Estimated Study Completion Date :||July 2024|
Instrumented assessment of muscle function
During the instrumented evaluations, the investigators will evaluate the possibility of measuring the passive and active function of the muscle using: - an isokinetic dynamometer, an ultrasound and elastography device, an electrical stimulation of the calf nerve
Other: Instrumented assessment of muscle function
During the instrumented evaluations, we will evaluate the possibility of measuring the passive and active function of the muscle using: - an isokinetic dynamometer, an ultrasound and elastography device, an electrical stimulation of the calf nerve
- proportion of usable data collected (ultrasound and elastographic images, EMG, force curves, etc.) compared to the expected usable data [ Time Frame: 14 weeks ]
- To measure the duration of the examinations [ Time Frame: 14 weeks ]
- the average length of stay of included patients [ Time Frame: 14 weeks ]
- the patient's opinion through a self-questionnaire of satisfaction [ Time Frame: 14 weeks ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||18 Years to 80 Years (Adult, Older Adult)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
- Patient aged 18 to 80 years;
- Validation by the medical team of an eccentric strengthening protocol:
presence of a paresis of the studied muscle considered as functionally (triceps surae rated at 2 or more on the MRC scale), more or less associated with HAM and muscl retraction;
- Patient with a traumatic or ischemic spinal cord injury of grade Asia Impairment Scale (AIS) C or D (incomplete motor impairment) < 6 months or stroke < 6 months;
- Patient is competent to consent (Boston Diagnostic Aphasia Examination [BDAE] score greater than or equal to 2);
- Patient hospitalized in the neurological PRM service of the Nantes University Hospital.
- History of functional surgery < 3 months ;
- Patient with osteoarticular lesions considered as a contraindication to to rehabilitation;
- Patient who is unlikely to adhere to the study program and/or not compliant compliant in the judgment of the investigator or refusing to participate in the study;
- Patients with a progressive pathology that contraindicates major muscular efforts (syrinx, cancer, etc.) (syrinx, cancer, cardiovascular instability...);
- Patients who are minors, protected adults, adults unable to express their consent or pregnant woman.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05415514
|Contact: Thomas Lecharte||02 44 76 89 89||Thomas.email@example.com|
|Principal Investigator:||Thomas Lecharte||Nantes University Hospital|
|Responsible Party:||Nantes University Hospital|
|Other Study ID Numbers:||
|First Posted:||June 13, 2022 Key Record Dates|
|Last Update Posted:||June 13, 2022|
|Last Verified:||June 2022|
|Studies a U.S. FDA-regulated Drug Product:||No|
|Studies a U.S. FDA-regulated Device Product:||No|
Nervous System Diseases